Emerald Health Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Emerald Health Therapeutics generated cash of -$17,107,000, which is less than the previous year. Cash used in financing activities reached the amount of -$9,996,000 last year. Net change in cash is therefore -$7,486,000.
Cash Flow
| 2012 | 27.42K | -4.96K | 0 |
|---|---|---|---|
| 2013 | -15.12K | -100.49K | -195K |
| 2014 | -1.25M | -218.95K | 3.19M |
| 2015 | -2.27M | -312.23K | 952.82K |
| 2016 | -2.04M | -243.99K | 5.42M |
| 2017 | -7.81M | -18.93M | 68.05M |
| 2018 | -29.08M | -62.47M | 83.08M |
| 2019 | -24.76M | -44.12M | 35.37M |
| 2020 | -10.50M | 54.39M | -20.41M |
| 2021 | -17.10M | 19.61M | -9.99M |
EMHTF Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 25.99M | 2.52M | 36.04M | 44.52M | 3.21M | 81.83K | 1.71M | 1 | 421.29K | 398.83K |
Operating activities | ||||||||||
Net income | -39.16M | -42.95M | -111.14M | -30.57M | -8.73M | -2.94M | -3.49M | -2.64M | -144.23K | -70.96K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.85M | 4.82M | 6.42M | 3.44M | 282.45K | 116.34K | 46.40K | 20.18K | 61.66K | 70.02K |
Stock-based compensation expense | 0 | 3.01M | 11.78M | 7.49M | 2.82M | 680.78K | 1.17M | 728.49K | 0 | 0 |
| Deferred income tax benefit | 0 | 3.01M | 11.78M | 7.49M | 2.82M | 680.78K | 1.17M | 728.49K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -386K | 571K | 1.65M | -3.19M | -223.84K | 13.43K | 408 | -42.54K | 10.51K | 0 |
Inventories | -772K | 3.59M | -6.96M | -2.92M | -333.02K | -129.40K | -164.47K | 0 | 0 | 0 |
Accounts payable | -6.42M | 3.61M | 1.38M | 6.22M | -878.85K | 164.14K | 98.18K | 0 | 48.41K | 0 |
Cash generated by operating activities | -17.10M | -10.50M | -24.76M | -29.08M | -7.81M | -2.04M | -2.27M | -1.25M | -15.12K | 27.42K |
Investing activities | ||||||||||
Purchases Of Investments | -64K | 0 | 0 | 0 | -250K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.00M | -3.53M | -24.11M | -18.68M | -2.25M | -244.99K | -312.23K | -218.95K | -493 | -4.96K |
Acquisitions Net | 20.52M | 58.70M | -20.00M | -41.79M | -16.22M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 19.61M | 54.39M | -44.12M | -62.47M | -18.93M | -243.99K | -312.23K | -218.95K | -100.49K | -4.96K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 5.6M | 22.76M | 60.6M | 40.94M | 3.83M | 0 | 3.18M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -612K | -25.79M | 0 | -91.55K | 0 | -186.31K | 0 | 0 | -195K | 0 |
Cash used in financing activities | -9.99M | -20.41M | 35.37M | 83.08M | 68.05M | 5.42M | 952.82K | 3.19M | -195K | 0 |
Net Change In Cash | -7.48M | 23.47M | -33.51M | -8.48M | 41.30M | 3.13M | -1.63M | 1.71M | -310.61K | 22.46K |
Cash at end of period | 18.51M | 25.99M | 2.52M | 36.04M | 44.52M | 3.21M | 81.83K | 1.71M | 110.67K | 421.29K |
| Data source |